160 related articles for article (PubMed ID: 26752990)
41. Development and in vitro evaluation of oral controlled release formulations of celecoxib using optimization techniques.
Chandran S; Ravi P; Saha RN
Yakugaku Zasshi; 2006 Jul; 126(7):505-14. PubMed ID: 16819273
[TBL] [Abstract][Full Text] [Related]
42. Transdermal delivery of sodium nonivamide propionate by iontophoresis.
Fang JY; Kuo CT; Huang YB; Wu PC; Tsai YH
Biol Pharm Bull; 1998 Oct; 21(10):1117-20. PubMed ID: 9821823
[TBL] [Abstract][Full Text] [Related]
43. Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation.
Akram M; Naqvi SB; Khan A
Pak J Pharm Sci; 2013 Mar; 26(2):323-32. PubMed ID: 23455203
[TBL] [Abstract][Full Text] [Related]
44. Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro.
Nugroho AK; Li L; Dijkstra D; Wikström H; Danhof M; Bouwstra JA
J Control Release; 2005 Mar; 103(2):393-403. PubMed ID: 15763622
[TBL] [Abstract][Full Text] [Related]
45. Transdermal therapeutic system of isradipine: effect of hydrophilic and hydrophobic matrix on in vitro and ex vivo characteristics.
Tirunagari M; Jangala VR; Khagga M; Gannu R
Arch Pharm Res; 2010 Jul; 33(7):1025-33. PubMed ID: 20661712
[TBL] [Abstract][Full Text] [Related]
46. Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin.
Al-Khalili M; Meidan VM; Michniak BB
AAPS PharmSci; 2003; 5(2):E14. PubMed ID: 12866941
[TBL] [Abstract][Full Text] [Related]
47. Controlled transport of timolol maleate through artificial membranes under passive and iontophoretic conditions.
Stamatialis DF; Rolevink HH; Koops GH
J Control Release; 2002 Jun; 81(3):335-45. PubMed ID: 12044572
[TBL] [Abstract][Full Text] [Related]
48. Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.
Nugroho AK; Della Pasqua O; Danhof M; Bouwstra JA
Pharm Res; 2004 Nov; 21(11):1974-84. PubMed ID: 15587918
[TBL] [Abstract][Full Text] [Related]
49. Development and Comparison of Nanosponge and Niosome based Gel for the Topical Delivery of Tazarotene.
Aggarwal G; Nagpal M; Kaur G
Pharm Nanotechnol; 2016; 4(3):213-228. PubMed ID: 29052500
[TBL] [Abstract][Full Text] [Related]
50. Transdermal delivery of nalbuphine and nalbuphine pivalate from hydrogels by passive diffusion and iontophoresis.
Fang JY; Sung KC; Hu OY; Chen HY
Arzneimittelforschung; 2001; 51(5):408-13. PubMed ID: 11413742
[TBL] [Abstract][Full Text] [Related]
51. Development and evaluation of transdermal patches of celecoxib.
Alam MI; Baboota S; Kohli K; Ali J; Ahuja A
PDA J Pharm Sci Technol; 2009; 63(5):429-37. PubMed ID: 20158049
[TBL] [Abstract][Full Text] [Related]
52. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
Kolli CS; Xiao J; Parsons DL; Babu RJ
Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925
[TBL] [Abstract][Full Text] [Related]
53. In situ Gel of Metoprolol Tartrate: Physicochemical Characterization, In vitro Diffusion and Histological Studies.
Khan S; Gajbhiye C; Singhavi DJ; Yeole P
Indian J Pharm Sci; 2012 Nov; 74(6):564-70. PubMed ID: 23798784
[TBL] [Abstract][Full Text] [Related]
54. Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro.
Kolli CS; Chadha G; Xiao J; Parsons DL; Babu RJ
J Drug Target; 2010 Nov; 18(9):657-64. PubMed ID: 20038213
[TBL] [Abstract][Full Text] [Related]
55. Development and evaluation of a monolithic floating drug delivery system for acyclovir.
Tavakoli N; Varshosaz J; Dorkoosh F; Motaghi S; Tamaddon L
Chem Pharm Bull (Tokyo); 2012; 60(2):172-7. PubMed ID: 22293475
[TBL] [Abstract][Full Text] [Related]
56. Kinetic assessment of iontophoretic delivery efficiency of niosomal tetracycline hydrochloride incorporated in electroconductive gel.
Duman G; Gucu E; Utku FS; Uner B; Macit M; Sarialtin S; Ozilgen M
Drug Deliv Transl Res; 2024 May; 14(5):1206-1217. PubMed ID: 37867180
[TBL] [Abstract][Full Text] [Related]
57. Development and evaluation of transdermal organogels containing nicorandil.
Madan JR; Sagar B; Chellappan DK; Dua K
Antiinflamm Antiallergy Agents Med Chem; 2013; 12(3):246-52. PubMed ID: 23746225
[TBL] [Abstract][Full Text] [Related]
58. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
59. Transdermal lontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes.
Doliwa A; Santoyo S; Ygartua P
Drug Dev Ind Pharm; 2001 Sep; 27(8):751-8. PubMed ID: 11699826
[TBL] [Abstract][Full Text] [Related]
60. Cutaneous iontophoretic delivery of CGP69669A, a sialyl Lewis(x) mimetic, in vitro.
Gratieri T; Wagner B; Kalaria D; Ernst B; Kalia YN
Exp Dermatol; 2012 Mar; 21(3):226-8. PubMed ID: 22379971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
